Literature DB >> 28278436

The anti-sepsis activity of the components of Huanglian Jiedu Decoction with high lipid A-binding affinity.

Guirong Chen1, Yubin Xu2, Jing Jing1, Brianna Mackie3, Xinchuan Zheng4, Xu Zhang1, Jing Wang1, Xuetao Li1.   

Abstract

Huanglian Jiedu Decoction (HJD), one of the classic recipes for relieving toxicity and fever, is a common method for treating sepsis in China. However, the effective components of HJD have not yet been identified. This experiment was carried out to elucidate the effective components of HJD against sepsis. Thus, seven fractions from HJD were tested using a biosensor to test their affinity for lipid A. The components obtained that had high lipid A-binding fractions were further separated, and their affinities to lipid A were assessed with the aid of a biosensor. The levels of LPS in the blood were measured, and pathology experiments were conducted. The LPS levels and mRNA expression analysis of TNF-α and IL-6 of the cell supernatant and animal tissue were evaluated to investigate the molecular mechanisms. Palmatine showed the highest affinity to lipid A and was evaluated by in vitro and in vivo experiments. The results of the in vitro and in vivo experiments indicated that the levels of LPS, TNF-α and IL-6 of the palmatine group were significantly lower than those of the sepsis model group (p<0.01). The group treated with palmatine showed strong neutralizing LPS activity in vivo. The palmatine group exhibited stronger protective activity on vital organs compared to the LPS-induced animal model. This verifies that HJD is a viable treatment option for sepsis given that there are multiple components in HJD that neutralize LPS, decrease the release of IL-6 and TNF-α induced by LPS, and protect vital organs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-sepsis activity; Huanglian Jiedu Decoction; LPS; Lipid A; Palmatine

Mesh:

Substances:

Year:  2017        PMID: 28278436     DOI: 10.1016/j.intimp.2017.02.025

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  11 in total

1.  Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways.

Authors:  Juan-Juan Cheng; Xing-Dong Ma; Gao-Xiang Ai; Qiu-Xia Yu; Xiao-Ying Chen; Fang Yan; Yu-Cui Li; Jian-Hui Xie; Zi-Ren Su; Qing-Feng Xie
Journal:  Drug Des Devel Ther       Date:  2022-07-02       Impact factor: 4.319

2.  Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity.

Authors:  Kai Wang; Jinqiu Rao; Tingting Zhang; Qing Gao; Jichao Zhang; Chenxi Guang; Liqin Ding; Feng Qiu
Journal:  Drug Des Devel Ther       Date:  2020-10-22       Impact factor: 4.162

3.  Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin.

Authors:  Shuhui Zhang; Lin Zhou; Mengdi Zhang; Yuehua Wang; Mengqi Wang; Jincheng Du; Wenwen Gu; Fuguang Kui; Jiahuan Li; Shengnan Geng; Gangjun Du
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

4.  Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway.

Authors:  Xing Li; Shizhang Wei; Xiao Ma; Haotian Li; Manyi Jing; Honghong Liu; Shengqi Niu; Yuling Tong; Lisheng Chen; Ying Wei; Sichen Ren; Yanling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-31       Impact factor: 2.629

5.  Study on the Molecular Basis of Huanglian Jiedu Decoction Against Atopic Dermatitis Integrating Chemistry, Biochemistry, and Metabolomics Strategies.

Authors:  Jing Chen; Saizhen Chen; Jinguang Chen; Bixin Shen; Zhengli Jiang; Yubin Xu
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

6.  The Anti-Inflammatory and Anti-Pruritus Mechanisms of Huanglian Jiedu Decoction in the Treatment of Atopic Dermatitis.

Authors:  Yubin Xu; Saizhen Chen; Lingling Zhang; Guirong Chen; Jinguang Chen
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

7.  Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking.

Authors:  Jing Yang; Chaotao Tang; Ruiri Jin; Bixia Liu; Peng Wang; Youxiang Chen; Chunyan Zeng
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

Review 8.  Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis.

Authors:  Xu-Hua Wang; Ding-Qiao Xu; Yan-Yan Chen; Shi-Jun Yue; Rui-Jia Fu; Lu Huang; Yu-Ping Tang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

Review 9.  Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations.

Authors:  Yiyu Qi; Qichun Zhang; Huaxu Zhu
Journal:  Chin Med       Date:  2019-12-18       Impact factor: 5.455

Review 10.  The Analgesic Properties of Corydalis yanhusuo.

Authors:  Lamees Alhassen; Travis Dabbous; Allyssa Ha; Leon Hoang Lam Dang; Olivier Civelli
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.